AstraZeneca ( (GB:AZN) ) has shared an update. AstraZeneca and Daiichi Sankyo have withdrawn their EU marketing application for datopotamab deruxtecan for advanced nonsquamous non-small cell lung ...
However, if you wake up regularly to find yourself or your pillow and sheets drenched in sweat this could be a red flag sign ...
A first-of-its-kind urine test for the early detection of lung cancer has been developed by University of Cambridge ...
Two sizes of vials for single use are available. The 4 mL and 16 mL vials contain 100 mg and 400 mg, respectively.
In fact, up to 14 per cent of people with lung cancer in the UK have never smoked, according to Cancer Research UK. What are the symptoms? Most nonsmokers have no early signs of lung cancer ...
Cancer survival rates have been boosted in some ... according to the charity Asthma + Lung UK. Its clinical lead, Dr Andrew Whittamore, says it can take time for people to even get a COPD ...
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
The new scanning technique allows the team to quantify the degree of improvement in ventilation when patients have a ...
Britain's benchmark FTSE 100 kicked off a holiday-shortened week on a higher note on Monday, while investors analysed data ...
"Cancer Research UK has been at the heart of lung cancer progress for more than 50 years, with over half a million lives saved from lung cancer since the mid-1980s. The announcement of this ...
AstraZeneca announced that its Tagrisso drug has got clearance in the European Union to treat an advanced form of non-small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback